Skip to content

Gynecological Tumors Unit

Request Appointment

What does the Unit treat?

The Gynecological Tumors Unit of HM CIOCC is a national reference unit, specialized in the treatment of ovarian carcinoma, uterine carcinoma, or cervical tumors.

At HM Hospitals (CIOCC), the Gynecological Tumors Unit focuses on:

  • Development of clinical trials with innovative therapies for patients with ovarian carcinoma, uterine carcinoma, or cervical tumors.
  • Treatment with TILs (Tumor-Infiltrating Lymphocytes) for patients with gynecological tumors. A technique in which we extract the patient’s own immune cells, multiply them in the laboratory, and reinfuse them so that they naturally attack the tumor.

Related Diseases

  • Uterine Cancer.
  • Ovarian Cancer.
  • Cervical Cancer.

Who is this Unit for?

The Genitourinary Tumors Unit is aimed at: 

  • Patients with ovarian carcinoma, uterine carcinoma, or cervical tumors.
  • Patients seeking to participate in clinical trials with innovative therapies.
  • Patients interested in TILs (Tumor-Infiltrating Lymphocytes) treatment.
  • Family members and caregivers seeking information and support for their loved ones with gynecological tumors.
  • Healthcare professionals who wish to refer patients for specialized gynecological tumor evaluation and treatment.

How do we approach it at HM Hospitals?

Surgery

We aim to remove as much of the tumor as possible, preserving the function of the reproductive organs to the maximum extent.

Chemotherapy

We use state-of-the-art medications to reach and destroy cancer cells that may be present anywhere in the body.

Radiotherapy

We direct high-energy beams to destroy cancer cells, minimizing damage to surrounding healthy tissues.

Targeted Therapies

They act on specific molecular targets of cancer cells, selectively disrupting their growth and spread.

Immunotherapy

Through drugs, we stimulate the patient’s immune system to naturally recognize and attack cancer cells.

TILs Treatment

We extract the patient’s own immune cells, multiply them in the laboratory, and reinfuse them so that they naturally attack the tumor.

Medical Team

facebookinstagramlinkedinxyoutubeopen_in_newtravelgroupcalendar_todaysearchmenuclose keyboard_arrow_leftkeyboard_arrow_rightdiagnosisecg_heart